These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. SOX4 induces epithelial-mesenchymal transition and contributes to breast cancer progression. Zhang J, Liang Q, Lei Y, Yao M, Li L, Gao X, Feng J, Zhang Y, Gao H, Liu DX, Lu J, Huang B. Cancer Res; 2012 Sep 01; 72(17):4597-608. PubMed ID: 22787120 [Abstract] [Full Text] [Related]
5. SCUBE3 is an endogenous TGF-β receptor ligand and regulates the epithelial-mesenchymal transition in lung cancer. Wu YY, Peck K, Chang YL, Pan SH, Cheng YF, Lin JC, Yang RB, Hong TM, Yang PC. Oncogene; 2011 Aug 25; 30(34):3682-93. PubMed ID: 21441952 [Abstract] [Full Text] [Related]
9. [TGF-beta signaling during bone metastasis of breast cancer and in-vivo imaging]. Imamura T, Hanyu A. Clin Calcium; 2008 Apr 25; 18(4):460-5. PubMed ID: 18379027 [Abstract] [Full Text] [Related]
13. ZNF217 is a marker of poor prognosis in breast cancer that drives epithelial-mesenchymal transition and invasion. Vendrell JA, Thollet A, Nguyen NT, Ghayad SE, Vinot S, Bièche I, Grisard E, Josserand V, Coll JL, Roux P, Corbo L, Treilleux I, Rimokh R, Cohen PA. Cancer Res; 2012 Jul 15; 72(14):3593-606. PubMed ID: 22593193 [Abstract] [Full Text] [Related]